AtaiBeckley Inc. - Common Stock (NQ:ATAI)

7.350 UNCHANGED

Last Price Updated: 4:00 PM EDT, Sep 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AtaiBeckley Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

31 32 Next >

atai Life Sciences' Drug Trial For Depression Fails To Deliver Expected Results, Stock Plunges ↗

January 06, 2023

Clinical-stage psychedelics biotech atai Life Sciences (NASDAQ: ATAI) shared the results of its NYC-based subsidiary NYC-based Perception Neuroscience’s Phase 2a study of proprietary R-ketamine PCN-101...

Via Benzinga

ATAI Life Sciences, Cybin Among Top Psychedelic Movers Of Today ↗

January 06, 2023

Via Benzinga

Dow Jumps 700 Points; S&P 500 Rises Over 2% ↗

January 06, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 700 points on Friday.

Via Benzinga

Nasdaq Gains 1.5%; Fate Therapeutics Shares Plunge ↗

January 06, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 550 points on Friday.

Via Benzinga

Greenbrier, Fate Therapeutics, AnaptysBio And Some Other Big Stocks Moving Lower On Friday ↗

January 06, 2023

U.S. stocks traded higher, with the Dow Jones gaining more than 500 points on Friday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Atai Life Sciences' Depression Candidate Faces Trial Setback, Shares Nosedive ↗

January 06, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From January 5, 2023 ↗

January 05, 2023

Via Benzinga

Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 06, 2023

Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.

Via Benzinga

Dow Rises Over 300 Points; US Adds 223,000 Jobs In December ↗

January 06, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Friday.

Via Benzinga

Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today ↗

January 04, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From January 2, 2023 ↗

January 02, 2023

Via Benzinga

Psychedelic Stock Gainers And Losers From December 29, 2022 ↗

December 29, 2022

Via Benzinga

Psychedelic Stock Gainers And Losers From December 28, 2022 ↗

December 28, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

January 06, 2023

During Friday's trading, 71 companies set new 52-week lows.

Via Benzinga

atai Life Sciences Announces Results from Phase 2a Trial of PCN-101 (R-ketamine) for Treatment-Resistant Depression

January 06, 2023

From atai Life Sciences

Via GlobeNewswire

Psychedelic Stock Gainers And Losers From December 27, 2022 ↗

December 27, 2022

Via Benzinga

Psychedelic Stock Gainers And Losers From December 26, 2022 ↗

December 26, 2022

Via Benzinga

Psychedelic Stock Gainers And Losers From December 23, 2022 ↗

December 23, 2022

Via Benzinga

Psychedelic Stock Gainers And Losers From January 3, 2023 ↗

January 03, 2023

Via Benzinga

What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways ↗

January 03, 2023

What a year for psychedelics!

Via Benzinga

6 Largest Psychedelic Drug Stocks Were -20% In December ↗

January 02, 2023

The Psychedelic Drug Stocks Index, which tracks the six largest psychedelic stocks researching the treatment of mental illnesses based on the use of one or more psychedelic substances, continued to...

Via Talk Markets

Psychedelic Stock Gainers And Losers From December 30, 2022 ↗

December 30, 2022

Via Benzinga

Psyched: Canada's Psychedelic Therapy Guidelines, $39M Series B For Next-Gen Drugs, Mexico's Ancestral Roots & More ↗

December 28, 2022

Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries

Via Benzinga

Cybin, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗

December 22, 2022

Via Benzinga

Largest Psychedelic Stocks -7.6% This Week; Now -21.7% This Month ↗

December 25, 2022

Highlighting the performance of the six stocks in our Psychedelic Drug Stocks Index, which are researching the treatment of mental illnesses using 10 different psychedelic substances.

Via Talk Markets

Cannabis Category Performances Ranged From +0.5% To -17% Last Week ↗

December 25, 2022

The 5 categories in the cannabis sector perform quite differently week-to-week and last week was no exception. Below is a summary of each category's performance last week, in descending order, since...

Via Talk Markets

Dow Rises 150 Points; Mission Produce Shares Slide ↗

December 23, 2022

U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Friday.

Via Benzinga

Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session ↗

December 23, 2022

Gainers

Via Benzinga

Dow Surges Over 100 Points; Crude Oil Rises Sharply ↗

December 23, 2022

U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining over 100 points on Friday.

Via Benzinga

atai Life Sciences Announces Results from the Kures Therapeutics Phase 1 Trial of KUR-101

December 23, 2022

From atai Life Sciences

Via GlobeNewswire

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

31 32 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.